BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35167337)

  • 1. Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy.
    Laucis AMB; Hochstedler KA; Schipper MJ; Paximadis PA; Boike TP; Bergsma DP; Movsas B; Kretzler A; Spratt DE; Dess RT; Mietzel MA; Dominello MM; Matuszak MM; Jagsi R; Hayman JA; Pierce LJ; Jolly S
    JCO Oncol Pract; 2022 Jun; 18(6):e1034-e1044. PubMed ID: 35167337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Singh AK; Lockett MA; Bradley JD
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):337-41. PubMed ID: 12527046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.
    Fang P; Swanick CW; Pezzi TA; Liao Z; Welsh J; Lin SH; Gomez DR
    Pract Radiat Oncol; 2017; 7(6):433-441. PubMed ID: 28428017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
    Patel AB; Edelman MJ; Kwok Y; Krasna MJ; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1106-12. PubMed ID: 15519781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
    Movsas B; Scott C; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Smith C; Axelrod R; Sarna L; Wasserman T; Byhardt R
    J Clin Oncol; 2005 Apr; 23(10):2145-54. PubMed ID: 15800308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer.
    Soni PD; Boonstra PS; Schipper MJ; Bazzi L; Dess RT; Matuszak MM; Kong FM; Hayman JA; Ten Haken RK; Lawrence TS; Kalemkerian GP; Jolly S
    J Thorac Oncol; 2017 Mar; 12(3):539-546. PubMed ID: 28161553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent racial disparities in refusal of resection in non-small cell lung cancer patients at high-volume and Black-serving institutions.
    Coaston TN; Sakowitz S; Chervu NL; Branche C; Shuch BM; Benharash P; Revels S
    Surgery; 2023 Dec; 174(6):1428-1435. PubMed ID: 37821266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
    Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
    Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):626-9. PubMed ID: 15936536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma.
    Giuliani ME; Lindsay PE; Kwan JY; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2015 May; 16(3):216-20. PubMed ID: 25532963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
    Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of treatment breaks and radiation-induced esophagitis and pneumonitis using amifostine in unresectable non-small cell lung cancer patients receiving definitive concurrent chemotherapy and radiation therapy: a prospective community-based clinical trial.
    Wynn RB; Mehta V
    Semin Oncol; 2005 Apr; 32(2 Suppl 3):S99-104. PubMed ID: 16015543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
    Zhao H; Zhu W; Xie P; Li H; Zhang X; Sun X; Yu J; Xing L
    Radiother Oncol; 2014 Jan; 110(1):132-6. PubMed ID: 24444526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide Consortium.
    Wilkie JR; Hochstedler KA; Schipper MJ; Matuszak MM; Paximadis P; Dominello MM; Grills I; Hayman JA; Dess R; Dragovic AF; Jagsi R; Pierce LJ; Spratt DE; Bergsma D; Boike TP; Movsas B; Jolly S;
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):942-950. PubMed ID: 34838865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
    McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
    Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.